Published by Benjamin Chiou on 14th October 2024
(Sharecast News) - GSK has announced positive results from a phase III trial of its depemokimab treatment for chronic rhinosinusitis with nasal polyps (CRSwNP).
URL: http://www.digitallook.com/dl/news/story/34620341/...